| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 234,519 | 198,303 | 151,107 | | Cost of Revenue | 30,646 | 26,984 | 21,684 | | | Gross Profit | 203,873 | 171,319 | 129,423 | | | Operating Expenses | | Research Development | 30,669 | 26,855 | 23,398 | | Selling General and Administrative | 149,116 | 117,771 | 86,850 | | Non Recurring |
-
|
-
|
-
| | Others | 3,582 | 3,019 | 2,603 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 20,506 | 23,674 | 16,572 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,639 | 3,591 | 2,600 | | Earnings Before Interest And Taxes | 22,145 | 27,265 | 19,172 | | Interest Expense | 175 | 114 | 326 | | Income Before Tax | 21,970 | 27,151 | 18,846 | | Income Tax Expense | 9,642 | 6,347 | (45,408) | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 12,328 | 20,804 | 64,254 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 12,328 | 20,804 | 64,254 | | Preferred Stock And Other Adjustments |
-
|
-
| (105,563) | | | Net Income Applicable To Common Shares | $12,328 | $20,804 | ($41,309) |
|
0.34% Nasdaq 
Income Statement
